Further in vivo and in vitro experiments found that Ir-pbt-Bpa can increase the level of intracellular HMGB1/ATP, CD8+ T cells, and memory T cells, as well as reduce regulatory T cells in tumor-bearing mice, resulting in strong and long-lasting antitumor immunity. The gene discussed is HMGB1; the disease is neoplasm.